Humalog kwikpen and Sinusitis - acute - a phase IV clinical study of FDA data

Summary:

Sinusitis - acute is reported as a side effect among people who take Humalog kwikpen (insulin lispro recombinant), especially for people who are female, 60+ old, also take Vitamin D3, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Sinusitis - acute when taking Humalog kwikpen. It is created by eHealthMe based on reports of 3,425 people who have side effects when taking Humalog kwikpen from the FDA, and is updated regularly.

What is Humalog kwikpen?

Humalog kwikpen has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 3,512 Humalog kwikpen users. Check the latest studies of Humalog kwikpen.

What is Sinusitis - acute?

Sinusitis - acute is found to be associated with 3,415 drugs and 2,776 conditions by eHealthMe. Check the latest studies of Sinusitis - acute.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 08, 2026

3,425 people reported to have side effects when taking Humalog kwikpen.
Among them, 15 people (0.44%) have Sinusitis - acute.

Could Humalog kwikpen cause Sinusitis - acute?

Among these 15 people:

What is the gender of people who have Sinusitis - acute when taking Humalog kwikpen? *

female: 60 %
male: 40 %

What is the age of people who have Sinusitis - acute when taking Humalog kwikpen? *

What are other drugs people take besides Humalog kwikpen? *

Vitamin D3: 7 people, 46.67%
Pantoprazole Sodium: 5 people, 33.33%
Flonase Allergy Relief: 4 people, 26.67%
Revlimid: 4 people, 26.67%
Lantus: 4 people, 26.67%
Losartan Potassium: 4 people, 26.67%
Zarxio: 3 people, 20.00%
Dexamethasone: 3 people, 20.00%
Aspirin: 3 people, 20.00%
Hydrochlorothiazide: 3 people, 20.00%

What are other side effects people have besides Sinusitis - acute? *

Nasopharyngitis (inflammation of the nasopharynx): 4 people, 26.67%
Blood Potassium Decreased: 4 people, 26.67%
Multiple Fractures: 3 people, 20.00%
Headache (pain in head): 3 people, 20.00%
Toothaches (tooth pain): 3 people, 20.00%
Spinal Fracture (fracture in one of vertebrae): 3 people, 20.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 13.33%
Itching: 2 people, 13.33%
Inflammation: 2 people, 13.33%
Hypotension (abnormally low blood pressure): 2 people, 13.33%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 4 people, 26.67%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 13.33%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 6.67%
Neurotrophic Keratopathy (decreased corneal sensitivity and poor corneal healing): 1 person, 6.67%
Immunodeficiency Common Variable: 1 person, 6.67%
Hyperkalemia (damage to or disease of the kidney): 1 person, 6.67%
High Blood Pressure: 1 person, 6.67%
Headache (pain in head): 1 person, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Humalog kwikpen and have Sinusitis - acute?

- Check whether Sinusitis - acute is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Humalog kwikpen:

Humalog kwikpen (3,512 reports)

Sinusitis - acute treatments and more:

Sinusitis - acute (153,485 reports)

Browse all side effects of Humalog kwikpen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis - acute:

Sinusitis - acute (3,415 drugs)

Browse all the conditions that are associated with Sinusitis - acute:

Sinusitis - acute (2,776 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on insulin lispro recombinant (the active ingredients of Humalog kwikpen) and Humalog kwikpen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.